Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • ATM/ATR
    (1)
  • Apoptosis
    (2)
  • COX
    (1)
  • Epigenetic Reader Domain
    (2)
  • MMP
    (2)
  • Raf
    (5)
  • Ras
    (5)
  • c-Met/HGFR
    (2)
  • c-Myc
    (2)
  • Others
    (91)
Filter
Search Result
Results for "

k-ras(g-12c) inhibitor 9

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    130
    TargetMol | Activity
  • Peptide Products
    3
    TargetMol | inventory
  • PROTAC Products
    7
    TargetMol | natural
  • Natural Products
    8
    TargetMol | composition
  • Recombinant Protein
    1
    TargetMol | Activity
K-Ras(G12C) inhibitor 9
T65561469337-91-4
K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C).
  • $48
In Stock
Size
QTY
pGlu-K(-NBD)-Q-R-L-G-N-Q-W-A-V-G-H-L-M-N
TP2304
pGlu-K(-NBD)-Q-R-L-G-N-Q-W-A-V-G-H-L-M-N is a peptides
  • $216
In Stock
Size
QTY
TargetMol | Inhibitor Sale
C-Met inhibitor D9
T67859299405-67-7
C-Met inhibitor D9 is a c-Met kinase inhibitor.
  • $195
In Stock
Size
QTY
RAS GTPase inhibitor 1
T126922252242-32-1In house
RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.
  • $373 TargetMol
In Stock
Size
QTY
TargetMol | Citations Cited
PKM2 inhibitor G
T67900904457-46-1
PKM2 inhibitor G is a inhibitor of pyruvate kinase.
  • $195
In Stock
Size
QTY
K-transporting ATPase α chain 1 Inhibitor 1
T9553816450-73-4In house
8-[(2,6-dimethylbenzyl)amino]-2,3-dimethylimidazo[1,2-a]pyridine-6-car is a H+/K+ ATPase inhibitor with IC50 of 0.38μM.
  • $148
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ACHE Inhibitor 12
T7735266309-83-9
ACHE Inhibitor 12 inhibited acetylcholinesterase with an IC50 value of 0.38 µM.
  • $195
In Stock
Size
QTY
GSK-3β inhibitor 12
T60472784170-07-6
GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.GSK-3β inhibitor 12 can be used for the study of Parkinson's in the presence of lipopolysaccharide induction.
  • $83
In Stock
Size
QTY
MMP-12 Inhibitor
T600831258003-93-8In house
MMP-12 Inhibitor is a selective inhibitor of MMP-12 with IC50s of 2, 160, 320, and 22.3 nM for human, mouse, rat, and sheep MMP-12.
  • $195
Backorder
Size
QTY
TargetMol | Citations Cited
c-Myc inhibitor 7
T720402883535-99-5In house
C-Myc Inhibitor 7, serving as both a c-Myc inhibitor and a multi-target protein degrader, effectively degrades proteins c-MYC, CK1α, GSPT1, and IKZF1/2/3 across various tumor cell types. It holds potential for research into diseases associated with high c-Myc expression, including cancer, cardiovascular and cerebrovascular conditions, and viral infections.
  • $1,520
Backorder
Size
QTY
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide
T9944246238-55-1In house
3-(9-Chloro-3-methyl-4-oxoisoxazolo[4,3-c]quinolin-5(4H)-yl)-N-(3,4,5-trimethoxyphenyl)benzeneacetamide inhibits multidrug resistance protein (MRP1).
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-Ras-IN-1
T546984783-01-7
K-Ras-IN-1, a K-Ras inhibitor, is characterized by its chemical formula C20H19ClN4O2S and is also known as N-[(1S)-3-cyclopropyl-1-[(6-fluoro-1H-benzimidazol-2-yl)sulfanyl]-2-oxo-1-(phenylmethyl)propyl]-4-fluorobenzenesulfonamide (compound [18, dashboard 819041] in brackets).
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Protein kinase G inhibitor-2
T9940612829-80-8
Protein kinase G inhibitor-2 exhibits antibacterial, antiviral, and antitumor activities.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-Ras G12C-IN-4
T117382376328-55-9
K-Ras G12C-IN-4, is a potent Covalent Inhibitor of KRASG12C..
  • $117
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-Ras(G12C) inhibitor 12
T65551469337-95-8
K-Ras(G12C) inhibitor 12 is an allosteric inhibitor of the oncogenic K-Ras(G12C) protein.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-Ras(G12C) Inhibitor 6
T37252060530-16-5
K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant, achieving 100% protein modification at 10 μM after 24 hours in vitro.
  • $57
In Stock
Size
QTY
TargetMol | Inhibitor Sale
K-Ras-PDEδ-IN-1
T86591841464-21-8
K-Ras-PDEδ-IN-1 is a potent inhibitor of competitive K-Ras-PDEδ that binds to the farnesyl binding pocket of PDEδ (Kd of 8 nM).
  • $80
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KRAS inhibitor-9
T8756300809-71-6
KRAS inhibitor-9 (DUN09716) is a potent KRAS inhibitor with Kd of 92 μM that blocks the formation of GTP-KRAS and downstream activation of KRAS. KRAS inhibitor-9 causes G2/M cell cycle arrest and induces apoptosis. KRAS inhibitor-9 selectively inhibits the proliferation of NSC-LC cells with KRAS mutation but not normal lung cells
  • $55
In Stock
Size
QTY
TargetMol | Inhibitor Sale
SIRT5 inhibitor 9
T78857
SIRT5 inhibitor 9 (compound 14), with an IC50 of 4.07 μM, is a competitive inhibitor of the sirtuin SIRT5, exhibiting potential anticancer properties [1].
  • Inquiry Price
Size
QTY
Bromodomain inhibitor-12 (edisylate)
T790942010124-27-1
Bromodomain Inhibitor-12 Edisylate (example 303) serves as a bromodomain inhibitor applicable to autoimmune and inflammatory disease research [1].
  • $1,520
8-10 weeks
Size
QTY
mTOR inhibitor-12
T79212
mTOR inhibitor-12 (Compound 11), a selective, brain-penetrant mTOR inhibitor, exhibits no genotoxicity risk and is utilized in research pertaining to central nervous system (CNS) diseases [1].
  • Inquiry Price
Size
QTY
c-Fms-IN-9
T106481628574-50-4
c-Fms-IN-9 is a c-FMS inhibitor that inhibits unphosphorylated c-FMS kinase (uFMS) and uKIT with IC50 values of <0.01 μM and 0.1-1 μM, respectively.
  • $1,670
6-8 weeks
Size
QTY
K-Ras ligand-Linker Conjugate 4
T180572378261-83-5
K-Ras ligand-Linker Conjugate 4 is a chemical compound combining a K-Ras recruiting ligand with a PROTAC linker, responsible for recruiting E3 ligases such as VHL, CRBN, MDM2, and IAP. It has the potential to be used in synthesizing PROTAC K-Ras Degrader-1, which shows a degradation efficacy of ≥70% in SW1573 cells[1].
  • $75
5 days
Size
QTY
Bromodomain inhibitor-9
T632201870849-34-5
Bromodomain inhibitor-9 is an inhibitor of Bromodomains that selectively inhibits the activity of BRD4-1 with a Kd value of 12 nM. Bromodomain inhibitor-9 can be used in studies of diseases related to systemic or lipid metabolism, tissue inflammation, fibrosis, or chronic autoimmune diseases.
  • $1,520
6-8 weeks
Size
QTY
6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purine
TNU0772205171-04-6
6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purine is a 2'-C-Methyl nucleoside and a halo-nucleoside.
  • Inquiry Price
7-10 days
Size
QTY
PI3K/mTOR Inhibitor-12
T723742891692-83-2
PI3K mTOR Inhibitor-12, a potent and selective orally active inhibitor, exhibits IC50 values of 0.06 nM for PI3Kα and 3.12 nM for mTOR, indicating significant antitumor activity with reduced liver toxicity [1].
  • $1,670
8-10 weeks
Size
QTY
c-Myc inhibitor 8
T726192173505-97-8
C-Myc Inhibitor 8 is an effective compound for cancer research, inhibiting cell viability across a range of cancer types and demonstrating growth suppression in human prostate and lung cancers within mouse models. This inhibitor specifically targets the c-Myc pathway, showcasing its potential utility in oncological studies.
  • $1,820
8-10 weeks
Size
QTY
MNK inhibitor 9
T727521889336-59-7
MNK Inhibitor 9 is a potent, selective inhibitor of MNK1/2, demonstrating IC50 values of 0.003 µM for both MNK1 and MNK2. It exhibits good cell permeability, making it suitable for tumor-related research.
  • $1,820
8-10 weeks
Size
QTY
c(phg-isoDGR-(NMe)k) TFA
T73720
C(phg-isoDGR-(NMe)k) TFA is a selective and potent ligand for α5β1-integrin, exhibiting an IC50 of 2.9 nM [1].
  • Inquiry Price
Size
QTY
CypD inhibitor C-9
T271101572646-93-5
CypD inhibitor C-9 is a CypD inhibitor, it attenuates mitochondrial and cellular perturbation insulted by Aß and calcium stress.
  • $1,520
6-8 weeks
Size
QTY
Ginsenoside C-K
T381139262-14-1
Ginsenoside C-K (Ginsenoside K) is a bacterial metabolite of G-Rb1 exhibiting anti-inflammatory effects by reducing iNOS and COX-2.
  • $110
In Stock
Size
QTY
c-Met inhibitor 1
T106551357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
  • $77
In Stock
Size
QTY
6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine
TNU07772095417-61-9
2’-C-Methyl nucleoside; 2/6/8-modified nucleoside
  • Inquiry Price
7-10 days
Size
QTY
Tuberculosis inhibitor 12
T80925793729-44-9
Tuberculosis Inhibitor 12, an oxadiazole derivative, effectively inhibits Mycobacterium tuberculosis, demonstrating inhibition rates of 82% and 78% at a concentration of 20 μM on 7H9-Tw-OADC media, respectively [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Topoisomerase I inhibitor 9
T809671228150-86-4
Topoisomerase I Inhibitor 9 (compound 3d), a specific inhibitor of leishmanial topoisomerase IB, exhibits antileishmanial activity, demonstrating an IC50 value of 34.81μM against L. donovani promastigotes [1].
  • Inquiry Price
8-10 weeks
Size
QTY
(3ξ,4ξ,5ξ,6ξ,7ξ,11ξ)-3,6-Dihydroxy-8-oxo-9-eremophilene-12-oic acid
T83555
(3ξ,4ξ,5ξ,6ξ,7ξ,11ξ)-3,6-Dihydroxy-8-oxo-9-eremophilene-12-oic acid, a phytotoxin recently identified in Alternaria alternata ssp. tenuissima isolates, is linked to fruit spots on apples.
  • Inquiry Price
Size
QTY
9(11),12-Oleanadien-3-ol
TN330894530-87-7
9(11),12-Oleanadien-3-ol is a natural product from Euonymus maackii.
  • $540
Backorder
Size
QTY
2-Amino-6-chloro-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine
TNU0096640725-74-2
2-Amino-6-chloro-9-(2-C-methyl-β-D-ribofuranosyl)-9H-purine is a 2'-C-Methyl nucleoside; Halo-nucleoside.
  • Inquiry Price
7-10 days
Size
QTY
ATX inhibitor 12
T63584
ATX inhibitor 12 is an orally active ATX inhibitor (IC50: 1.72 nM). In C57Bl/6J mice, oral administration of ATX inhibitor 12 at a dose of 60 mg/kg was effective in inhibiting structural lung damage and reducing fibrotic lesions.
  • $1,520
10-14 weeks
Size
QTY
K-Ras G12C-IN-3
T117371629268-19-4
Heterocyclic compounds as covalent inhibitors of G12C mutant K-Ras protein useful for treating cancers.K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C.
  • $347
6-8 weeks
Size
QTY
c-Met-IN-12
T640802426675-70-7
c-Met-IN-12 is a selective, orally active type II c-Met kinase inhibitor (IC50: 10.6 nM). c-Met-IN-12 is a high inhibitor of AXL, Mer and TYRO3 kinases (>80% inhibition at 1 μM). c-Met-IN-12 can be used as a scaffold to further enhance kinase selectivity. c-Met-IN-12 exhibits anti-tumour activity.
  • $1,520
6-8 weeks
Size
QTY
3(Z),6(Z),9(Z),12(Z),15(Z)-Octadecapentaenoic Acid
T8366051592-59-7
3(Z),6(Z),9(Z),12(Z),15(Z)-Octadecapentaenoic acid, a microalgal polyunsaturated fatty acid (PUFA), is identified in G. kowalevskii and serves as a chemotaxonomic biomarker for microalgae and dinoflagellates.
  • $65
35 days
Size
QTY
6-Methyl-9-(2-C-Methyl-beta-D-ribofuranosyl) purine
TNU01012095417-06-2
2’-C-Methyl nucleoside; 2/6/8- modified nucleoside
  • Inquiry Price
7-10 days
Size
QTY
Topoisomerase II inhibitor 9
T633042413901-61-6
Topoisomerase II inhibitor 9 is a Topo II inhibitor (IC50: 0.97 μM) and DNA embedding agent (IC50: 43.51 μM) that blocks the Hep G-2 cell cycle in the G2/M phase and induces apoptosis.
  • $1,520
6-8 weeks
Size
QTY
KRAS G12D inhibitor 9
T640312648551-39-5
KRAS G12D inhibitor 9 is a potent agent targeting KRAS G12D, an important member of the RAS protein family involved in intracellular signaling crucial for growth and development. This inhibitor shows significant research potential for KRAS G12D-mediated cancer.
  • $2,140
10-14 weeks
Size
QTY
KRAS inhibitor-12
T627512230874-00-5
KRAS inhibitor-12 (compound 6-1) is a potent inhibitor of KRAS G12C (IC50: 0.537 μM), exhibiting p-ERK inhibition in MIA PaCA-2 and A549 cells with IC50 values of 1.3 and 3.7 μM, respectively. KRAS inhibitor-12 has potential for study in pancreatic, colorectal, and lung cancers.
  • $2,140
8-10 weeks
Size
QTY
K-Ras G12C-IN-1
T117351629265-17-3
K-Ras G12C-IN-1 is a novel, irreversible inhibitor of mutant K-Ras G12C.
  • $1,530
8-10 weeks
Size
QTY
Caspase-9 Inhibitor III
T72281403848-57-7
Caspase-9 Inhibitor III (Ac-LEHD-cmk), a caspase-9 inhibitor, demonstrates protective effects against ischemia-reperfusion-induced myocardial injury.
  • $1,180
6-8 weeks
Size
QTY
6-Mthoxy-9-beta-D-(2-C-ethynyl-ribofuranosyl) purine
T75073
6-Methoxy-9-beta-D-(2-C-ethynyl-ribofuranosyl) purine is a purine nucleoside analog with broad antitumor activity targeting indolent lymphoid malignancies. Its anticancer mechanisms include inhibition of DNA synthesis and induction of apoptosis [1].
  • Inquiry Price
Size
QTY
K-Ras ligand-Linker Conjugate 6
T180592378261-89-1
K-Ras ligand-Linker Conjugate 6 is a chemical compound that combines a ligand for the K-Ras recruiting moiety and a PROTAC linker. It can recruit E3 ligases, including VHL, CRBN, MDM2, and IAP. K-Ras ligand-Linker Conjugate 6 is particularly useful in synthesizing PROTAC K-Ras Degrader-1, which achieves ≥70% degradation efficacy in SW1573 cells[1].
  • $124
5 days
Size
QTY